img

Global Human Hyperimmune Globulins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Hyperimmune Globulins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Human Hyperimmune Globulins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Hyperimmune Globulins market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Government Institutions and Private Sector are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Human Hyperimmune Globulins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Human Hyperimmune Globulins key manufacturers include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. CSL Behring, Grifols, Biotest are top 3 players and held % sales share in total in 2022.
Human Hyperimmune Globulins can be divided into Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins and Others, etc. Hepatitis B Immunoglobulins is the mainstream product in the market, accounting for % sales share globally in 2022.
Human Hyperimmune Globulins is widely used in various fields, such as Government Institutions, Private Sector and Others,, etc. Government Institutions provides greatest supports to the Human Hyperimmune Globulins industry development. In 2022, global % sales of Human Hyperimmune Globulins went into Government Institutions filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Hyperimmune Globulins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Segment by Type
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others

Segment by Application


Government Institutions
Private Sector
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Hyperimmune Globulins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Hyperimmune Globulins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Hyperimmune Globulins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Hyperimmune Globulins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Hyperimmune Globulins introduction, etc. Human Hyperimmune Globulins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Hyperimmune Globulins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Human Hyperimmune Globulins Market Overview
1.1 Human Hyperimmune Globulins Product Overview
1.2 Human Hyperimmune Globulins Market Segment by Type
1.2.1 Hepatitis B Immunoglobulins
1.2.2 Rabies Immunoglobulins
1.2.3 Tetanus Immunoglobulins
1.2.4 Others
1.3 Global Human Hyperimmune Globulins Market Size by Type
1.3.1 Global Human Hyperimmune Globulins Market Size Overview by Type (2018-2029)
1.3.2 Global Human Hyperimmune Globulins Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Hyperimmune Globulins Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Hyperimmune Globulins Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Hyperimmune Globulins Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Hyperimmune Globulins Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Hyperimmune Globulins Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Hyperimmune Globulins Sales Breakdown by Type (2018-2024)
2 Global Human Hyperimmune Globulins Market Competition by Company
2.1 Global Top Players by Human Hyperimmune Globulins Sales (2018-2024)
2.2 Global Top Players by Human Hyperimmune Globulins Revenue (2018-2024)
2.3 Global Top Players by Human Hyperimmune Globulins Price (2018-2024)
2.4 Global Top Manufacturers Human Hyperimmune Globulins Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Hyperimmune Globulins Market Competitive Situation and Trends
2.5.1 Human Hyperimmune Globulins Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Hyperimmune Globulins Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Hyperimmune Globulins as of 2022)
2.7 Date of Key Manufacturers Enter into Human Hyperimmune Globulins Market
2.8 Key Manufacturers Human Hyperimmune Globulins Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Hyperimmune Globulins Status and Outlook by Region
3.1 Global Human Hyperimmune Globulins Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Hyperimmune Globulins Historic Market Size by Region
3.2.1 Global Human Hyperimmune Globulins Sales in Volume by Region (2018-2024)
3.2.2 Global Human Hyperimmune Globulins Sales in Value by Region (2018-2024)
3.2.3 Global Human Hyperimmune Globulins Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Hyperimmune Globulins Forecasted Market Size by Region
3.3.1 Global Human Hyperimmune Globulins Sales in Volume by Region (2024-2029)
3.3.2 Global Human Hyperimmune Globulins Sales in Value by Region (2024-2029)
3.3.3 Global Human Hyperimmune Globulins Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Hyperimmune Globulins by Application
4.1 Human Hyperimmune Globulins Market Segment by Application
4.1.1 Government Institutions
4.1.2 Private Sector
4.1.3 Others
4.2 Global Human Hyperimmune Globulins Market Size by Application
4.2.1 Global Human Hyperimmune Globulins Market Size Overview by Application (2018-2029)
4.2.2 Global Human Hyperimmune Globulins Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Hyperimmune Globulins Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Hyperimmune Globulins Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Hyperimmune Globulins Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Hyperimmune Globulins Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Hyperimmune Globulins Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Hyperimmune Globulins Sales Breakdown by Application (2018-2024)
5 North America Human Hyperimmune Globulins by Country
5.1 North America Human Hyperimmune Globulins Historic Market Size by Country
5.1.1 North America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Hyperimmune Globulins Sales in Volume by Country (2018-2024)
5.1.3 North America Human Hyperimmune Globulins Sales in Value by Country (2018-2024)
5.2 North America Human Hyperimmune Globulins Forecasted Market Size by Country
5.2.1 North America Human Hyperimmune Globulins Sales in Volume by Country (2024-2029)
5.2.2 North America Human Hyperimmune Globulins Sales in Value by Country (2024-2029)
6 Europe Human Hyperimmune Globulins by Country
6.1 Europe Human Hyperimmune Globulins Historic Market Size by Country
6.1.1 Europe Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Hyperimmune Globulins Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Hyperimmune Globulins Sales in Value by Country (2018-2024)
6.2 Europe Human Hyperimmune Globulins Forecasted Market Size by Country
6.2.1 Europe Human Hyperimmune Globulins Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Hyperimmune Globulins Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Hyperimmune Globulins by Region
7.1 Asia-Pacific Human Hyperimmune Globulins Historic Market Size by Region
7.1.1 Asia-Pacific Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Hyperimmune Globulins Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Hyperimmune Globulins Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Hyperimmune Globulins Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Hyperimmune Globulins Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Hyperimmune Globulins Sales in Value by Region (2024-2029)
8 Latin America Human Hyperimmune Globulins by Country
8.1 Latin America Human Hyperimmune Globulins Historic Market Size by Country
8.1.1 Latin America Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Hyperimmune Globulins Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Hyperimmune Globulins Sales in Value by Country (2018-2024)
8.2 Latin America Human Hyperimmune Globulins Forecasted Market Size by Country
8.2.1 Latin America Human Hyperimmune Globulins Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Hyperimmune Globulins Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Hyperimmune Globulins by Country
9.1 Middle East and Africa Human Hyperimmune Globulins Historic Market Size by Country
9.1.1 Middle East and Africa Human Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Hyperimmune Globulins Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Hyperimmune Globulins Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Hyperimmune Globulins Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Hyperimmune Globulins Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Hyperimmune Globulins Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL Behring
10.1.1 CSL Behring Company Information
10.1.2 CSL Behring Introduction and Business Overview
10.1.3 CSL Behring Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CSL Behring Human Hyperimmune Globulins Products Offered
10.1.5 CSL Behring Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Grifols Human Hyperimmune Globulins Products Offered
10.2.5 Grifols Recent Development
10.3 Biotest
10.3.1 Biotest Company Information
10.3.2 Biotest Introduction and Business Overview
10.3.3 Biotest Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biotest Human Hyperimmune Globulins Products Offered
10.3.5 Biotest Recent Development
10.4 Kedrion
10.4.1 Kedrion Company Information
10.4.2 Kedrion Introduction and Business Overview
10.4.3 Kedrion Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Kedrion Human Hyperimmune Globulins Products Offered
10.4.5 Kedrion Recent Development
10.5 CBPO
10.5.1 CBPO Company Information
10.5.2 CBPO Introduction and Business Overview
10.5.3 CBPO Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.5.4 CBPO Human Hyperimmune Globulins Products Offered
10.5.5 CBPO Recent Development
10.6 Emergent (Cangene)
10.6.1 Emergent (Cangene) Company Information
10.6.2 Emergent (Cangene) Introduction and Business Overview
10.6.3 Emergent (Cangene) Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Emergent (Cangene) Human Hyperimmune Globulins Products Offered
10.6.5 Emergent (Cangene) Recent Development
10.7 Kamada
10.7.1 Kamada Company Information
10.7.2 Kamada Introduction and Business Overview
10.7.3 Kamada Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Kamada Human Hyperimmune Globulins Products Offered
10.7.5 Kamada Recent Development
10.8 CNBG
10.8.1 CNBG Company Information
10.8.2 CNBG Introduction and Business Overview
10.8.3 CNBG Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.8.4 CNBG Human Hyperimmune Globulins Products Offered
10.8.5 CNBG Recent Development
10.9 Hualan Bio
10.9.1 Hualan Bio Company Information
10.9.2 Hualan Bio Introduction and Business Overview
10.9.3 Hualan Bio Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Hualan Bio Human Hyperimmune Globulins Products Offered
10.9.5 Hualan Bio Recent Development
10.10 Shanghai RAAS
10.10.1 Shanghai RAAS Company Information
10.10.2 Shanghai RAAS Introduction and Business Overview
10.10.3 Shanghai RAAS Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Shanghai RAAS Human Hyperimmune Globulins Products Offered
10.10.5 Shanghai RAAS Recent Development
10.11 Sichuan Yuanda Shuyang
10.11.1 Sichuan Yuanda Shuyang Company Information
10.11.2 Sichuan Yuanda Shuyang Introduction and Business Overview
10.11.3 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Products Offered
10.11.5 Sichuan Yuanda Shuyang Recent Development
10.12 ADMA Biologics
10.12.1 ADMA Biologics Company Information
10.12.2 ADMA Biologics Introduction and Business Overview
10.12.3 ADMA Biologics Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2018-2024)
10.12.4 ADMA Biologics Human Hyperimmune Globulins Products Offered
10.12.5 ADMA Biologics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Hyperimmune Globulins Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Hyperimmune Globulins Industrial Chain Analysis
11.4 Human Hyperimmune Globulins Market Dynamics
11.4.1 Human Hyperimmune Globulins Industry Trends
11.4.2 Human Hyperimmune Globulins Market Drivers
11.4.3 Human Hyperimmune Globulins Market Challenges
11.4.4 Human Hyperimmune Globulins Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Hyperimmune Globulins Distributors
12.3 Human Hyperimmune Globulins Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Hepatitis B Immunoglobulins
Table 2. Major Company of Rabies Immunoglobulins
Table 3. Major Company of Tetanus Immunoglobulins
Table 4. Major Company of Others
Table 5. Global Human Hyperimmune Globulins Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 7. Global Human Hyperimmune Globulins Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Human Hyperimmune Globulins Sales by Type (2018-2024) & (US& Million)
Table 9. Global Human Hyperimmune Globulins Market Share in Value by Type (2018-2024)
Table 10. Global Human Hyperimmune Globulins Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Human Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)
Table 12. Global Human Hyperimmune Globulins Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Human Hyperimmune Globulins Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Human Hyperimmune Globulins Sales Market Share in Value by Type (2024-2029)
Table 15. Global Human Hyperimmune Globulins Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 17. North America Human Hyperimmune Globulins Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Human Hyperimmune Globulins Sales (K Units) by Type (2018-2024)
Table 19. Europe Human Hyperimmune Globulins Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Human Hyperimmune Globulins Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Human Hyperimmune Globulins Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Human Hyperimmune Globulins Sales (K Units) by Type (2018-2024)
Table 23. Latin America Human Hyperimmune Globulins Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Human Hyperimmune Globulins Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Human Hyperimmune Globulins Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Human Hyperimmune Globulins Sales by Company (2018-2024) & (K Units)
Table 27. Global Human Hyperimmune Globulins Sales Share by Company (2018-2024)
Table 28. Global Human Hyperimmune Globulins Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Human Hyperimmune Globulins Revenue Share by Company (2018-2024)
Table 30. Global Market Human Hyperimmune Globulins Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Human Hyperimmune Globulins Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Human Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Hyperimmune Globulins as of 2022)
Table 34. Date of Key Manufacturers Enter into Human Hyperimmune Globulins Market
Table 35. Key Manufacturers Human Hyperimmune Globulins Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Human Hyperimmune Globulins Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Human Hyperimmune Globulins Sales by Region (2018-2024) & (K Units)
Table 39. Global Human Hyperimmune Globulins Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Human Hyperimmune Globulins Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Human Hyperimmune Globulins Sales Market Share in Value by Region (2018-2024)
Table 42. Global Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Human Hyperimmune Globulins Sales by Region (2024-2029) & (K Units)
Table 44. Global Human Hyperimmune Globulins Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Human Hyperimmune Globulins Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Human Hyperimmune Globulins Sales Market Share in Value by Region (2024-2029)
Table 47. Global Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Human Hyperimmune Globulins Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Human Hyperimmune Globulins Sales by Application (2018-2024) & (K Units)
Table 50. Global Human Hyperimmune Globulins Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Human Hyperimmune Globulins Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Human Hyperimmune Globulins Sales Market Share in Value by Application (2018-2024)
Table 53. Global Human Hyperimmune Globulins Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Human Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)
Table 55. Global Human Hyperimmune Globulins Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Human Hyperimmune Globulins Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Human Hyperimmune Globulins Sales Market Share in Value by Application (2024-2029)
Table 58. Global Human Hyperimmune Globulins Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Human Hyperimmune Globulins Sales by Application (2018-2024) (K Units)
Table 60. North America Human Hyperimmune Globulins Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Human Hyperimmune Globulins Sales by Application (2018-2024) (K Units)
Table 62. Europe Human Hyperimmune Globulins Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Human Hyperimmune Globulins Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Human Hyperimmune Globulins Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Human Hyperimmune Globulins Sales by Application (2018-2024) (K Units)
Table 66. Latin America Human Hyperimmune Globulins Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Human Hyperimmune Globulins Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Human Hyperimmune Globulins Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Human Hyperimmune Globulins Sales by Country (2018-2024) & (K Units)
Table 70. North America Human Hyperimmune Globulins Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Human Hyperimmune Globulins Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Human Hyperimmune Globulins Sales Market Share in Value by Country (2018-2024)
Table 73. North America Human Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)
Table 74. North America Human Hyperimmune Globulins Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Human Hyperimmune Globulins Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Human Hyperimmune Globulins Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Human Hyperimmune Globulins Sales by Country (2018-2024) & (K Units)
Table 78. Europe Human Hyperimmune Globulins Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Human Hyperimmune Globulins Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Human Hyperimmune Globulins Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Human Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)
Table 82. Europe Human Hyperimmune Globulins Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Human Hyperimmune Globulins Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Human Hyperimmune Globulins Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Human Hyperimmune Globulins Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Human Hyperimmune Globulins Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Human Hyperimmune Globulins Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Human Hyperimmune Globulins Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Human Hyperimmune Globulins Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Human Hyperimmune Globulins Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Human Hyperimmune Globulins Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Human Hyperimmune Globulins Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Human Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Human Hyperimmune Globulins Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Human Hyperimmune Globulins Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Human Hyperimmune Globulins Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Human Hyperimmune Globulins Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Human Hyperimmune Globulins Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Human Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Human Hyperimmune Globulins Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Value by Country (2024-2029)
Table 109. CSL Behring Company Information
Table 110. CSL Behring Introduction and Business Overview
Table 111. CSL Behring Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. CSL Behring Human Hyperimmune Globulins Product
Table 113. CSL Behring Recent Development
Table 114. Grifols Company Information
Table 115. Grifols Introduction and Business Overview
Table 116. Grifols Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Grifols Human Hyperimmune Globulins Product
Table 118. Grifols Recent Development
Table 119. Biotest Company Information
Table 120. Biotest Introduction and Business Overview
Table 121. Biotest Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Biotest Human Hyperimmune Globulins Product
Table 123. Biotest Recent Development
Table 124. Kedrion Company Information
Table 125. Kedrion Introduction and Business Overview
Table 126. Kedrion Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Kedrion Human Hyperimmune Globulins Product
Table 128. Kedrion Recent Development
Table 129. CBPO Company Information
Table 130. CBPO Introduction and Business Overview
Table 131. CBPO Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. CBPO Human Hyperimmune Globulins Product
Table 133. CBPO Recent Development
Table 134. Emergent (Cangene) Company Information
Table 135. Emergent (Cangene) Introduction and Business Overview
Table 136. Emergent (Cangene) Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Emergent (Cangene) Human Hyperimmune Globulins Product
Table 138. Emergent (Cangene) Recent Development
Table 139. Kamada Company Information
Table 140. Kamada Introduction and Business Overview
Table 141. Kamada Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Kamada Human Hyperimmune Globulins Product
Table 143. Kamada Recent Development
Table 144. CNBG Company Information
Table 145. CNBG Introduction and Business Overview
Table 146. CNBG Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. CNBG Human Hyperimmune Globulins Product
Table 148. CNBG Recent Development
Table 149. Hualan Bio Company Information
Table 150. Hualan Bio Introduction and Business Overview
Table 151. Hualan Bio Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Hualan Bio Human Hyperimmune Globulins Product
Table 153. Hualan Bio Recent Development
Table 154. Shanghai RAAS Company Information
Table 155. Shanghai RAAS Introduction and Business Overview
Table 156. Shanghai RAAS Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Shanghai RAAS Human Hyperimmune Globulins Product
Table 158. Shanghai RAAS Recent Development
Table 159. Sichuan Yuanda Shuyang Company Information
Table 160. Sichuan Yuanda Shuyang Introduction and Business Overview
Table 161. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product
Table 163. Sichuan Yuanda Shuyang Recent Development
Table 164. ADMA Biologics Company Information
Table 165. ADMA Biologics Introduction and Business Overview
Table 166. ADMA Biologics Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. ADMA Biologics Human Hyperimmune Globulins Product
Table 168. ADMA Biologics Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Human Hyperimmune Globulins Market Trends
Table 172. Human Hyperimmune Globulins Market Drivers
Table 173. Human Hyperimmune Globulins Market Challenges
Table 174. Human Hyperimmune Globulins Market Restraints
Table 175. Human Hyperimmune Globulins Distributors List
Table 176. Human Hyperimmune Globulins Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hyperimmune Globulins Product Picture
Figure 2. Global Human Hyperimmune Globulins Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Hyperimmune Globulins Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Human Hyperimmune Globulins Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Hepatitis B Immunoglobulins
Figure 6. Global Hepatitis B Immunoglobulins Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Rabies Immunoglobulins
Figure 8. Global Rabies Immunoglobulins Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Tetanus Immunoglobulins
Figure 10. Global Tetanus Immunoglobulins Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Human Hyperimmune Globulins Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Human Hyperimmune Globulins Sales Market Share by Type in 2022 & 2029
Figure 15. North America Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2022
Figure 16. North America Human Hyperimmune Globulins Sales Market Share in Value by Type in 2022
Figure 17. Europe Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2022
Figure 18. Europe Human Hyperimmune Globulins Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Value by Type in 2022
Figure 21. Latin America Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Human Hyperimmune Globulins Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Hyperimmune Globulins Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Hyperimmune Globulins Revenue in 2022
Figure 27. Human Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Government Institutions
Figure 29. Global Government Institutions Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Private Sector
Figure 31. Global Private Sector Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Human Hyperimmune Globulins Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Human Hyperimmune Globulins Sales Market Share by Application in 2022 & 2029
Figure 36. North America Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2022
Figure 37. North America Human Hyperimmune Globulins Sales Market Share in Value by Application in 2022
Figure 38. Europe Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2022
Figure 39. Europe Human Hyperimmune Globulins Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Human Hyperimmune Globulins Sales Market Share in Value by Application in 2022
Figure 42. Latin America Human Hyperimmune Globulins Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Human Hyperimmune Globulins Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Human Hyperimmune Globulins Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Human Hyperimmune Globulins Manufacturing Cost Structure
Figure 47. Human Hyperimmune Globulins Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries